Ask your team which referral sources produce clean first-pass approvals and which produce three rounds of records requests. If nobody can answer, you are absorbing the cost of the difference without being able to see it.
Most prior-auth tooling is built one note at a time: a case is ready, someone assembles a packet, the packet goes out, the clock starts. That is worth doing — our surgeon-side agent does exactly that, and does it in a minute instead of forty-five. But it is downstream of the moment the cost is created.
The cost is created earlier, at the referral. A patient arrives, the case is clinically obvious, and the chart does not carry the documented conservative-care trial the payer requires. Everything after that is retroactive record chasing, and it is invisible in the P&L because it looks like staff time rather than delayed cases.
The best answer to a documentation gap is a referral source that closes it for you. Patients who complete a multi-month value-based musculoskeletal care period without improving carry supervised, outcome-measured conservative management on the payer’s own schedule — several times the documentation bar coverage requires. They arrive appropriate and approvable.
That is the same argument from the other end: the best surgical referral in 2027 is a documented failure. A service line that measures authorisation turnaround by referral source will find these sources quickly, and will be able to prove which ones are worth cultivating.
Under CMS-0057-F, impacted payers — Medicare Advantage, state Medicaid and CHIP, and federally-facilitated exchange issuers — must stand up a Prior Authorization API by January 1, 2027, alongside Patient Access, Provider Access and Payer-to-Payer. Decision clocks of 72 hours expedited and 7 days standard, with specific denial reasons, are already in force.
Whether a service needs authorisation, what documentation is nominally required, submitting the request, and returning a structured answer. Real progress, and it will become table stakes.
Knowing a service requires six weeks of documented conservative therapy does not locate that therapy in your chart, judge whether the notes are recent enough, assemble the package, work the request-for-information loop, or retain it in a form that survives a payment dispute later.
The shape of the next two years is not subtle: 2027 is a thin early-adopter year, and 2028 is a compliance-driven buying wave. Service lines that use 2027 to fix their documentation pathway will spend 2028 buying a transaction layer that plugs into something already working. The rest will buy a transaction layer that faithfully transmits an incomplete chart.
Not clinical, legal, or financial advice. Coverage criteria and authorisation requirements vary by payer, plan, state and MAC jurisdiction. CY2028 MIPS ePA provisions referenced here are proposed, not final. Sources: AMA Prior Authorization Physician Survey; HHS Office of Inspector General; CMS-0057-F.